You are in

/ Home / About Dana-Farber / News & Publications / Publications / Paths of Progress / Spring/Summer 2009

Main Menu

• Mission and Values
• Dana-Farber Patient Safety Aim
• Mission Possible Campaign
• Visitor's Guide
• History
• News & Publications
  • Press Releases
  • Publications
  • Video Newsroom
  • For Journalists
  • Facts & Figures
  • Dana-Farber in the News
  • Links to Journals
  • The Cancer Treatment Revolution
• Careers at Dana-Farber
• Yawkey Center for Cancer Care
• Dana-Farber Physicians & Researchers
• Medical Education & Training
• Community Outreach
• Collaborations
• Dana-Farber Directories
• Dana-Farber Awards
• Leadership Profiles
• Why Dana-Farber?
• Social Networking
• Satellite Centers
• Online Stores

Paths of Progress

Making Cancer Mortal: Inside the cancer stem cell debate

Spring/Summer
Volume 18, Number 1

Contents

• Features
• Departments
• Credits

• From the President

Features

• Making Cancer Mortal
  By Richard Saltus

  Experts debate the existence and importance of cancer stem cells.

• Looking and Listening
  By Rob Levy

  Dana-Farber researchers seek new strategies to identify biomarkers, telltale compounds that may provide an early read on a tumor and how it will respond to therapy.

• The Best of Friends
  By Cindy Hutter

  Three young women share the bond of surviving childhood cancer and the close relationships formed because of it.

• Views from the Zakim Center: A Photo Essay
  By Saul Wisnia

  Lenny Zakim's legacy continues through treatment and research underway at Dana-Farber’s Leonard P. Zakim Center for Integrative Therapies.

• Throwing a Wrench into Cancer’s Defenses
  By Richard Saltus

  Scientists are exploring new tools and strategies that may help prevent cancer cells from becoming resistant to radiation or chemotherapy.

• First Person: Megan Hanna
  Edited by Debra Bradley Ruder

  How a daughter's death motivated one mom to switch careers and work toward a cure for neuroblastoma, a rare cancer of the nervous system.

• Back cover image

Departments

• Dateline – news around the Institute

  Including Dana-Farber's newest satellite center, new co-chairs for patient councils, and the Department of Imaging expansion.

• Discoveries

  Including key research on flu viruses, new findings on the DNA of lung cancer cells, and the search for a cancer cell "self-destruct" button.

• 2008 Annual Report

• About us

Credits

President, Dana-Farber Cancer Institute Edward J. Benz Jr., MD
Chief Medical Officer Lawrence N. Shulman, MD
Chief Scientific Officer Barrett J. Rollins, MD
Chief Clinical Research Officer Philip W. Kantoff, MD
Chief of Staff Stephen E. Sallan, MD
Chair, Medical Oncology James D. Griffin, MD
Chair, Pediatric Oncology Stuart H. Orkin, MD
Chair, Radiation Oncology Jay R. Harris, MD
Chair, Executive Committee for Research David M. Livingston, MD
Senior VP for Experimental Medicine Lee M. Nadler, MD
Senior VP for Patient Care Services, Chief Nurse Patricia Reid Ponte, RN, DNSc, FAAN
Senior VP for Research Beverly R. Ginsburg, MBA

Senior VP for Communications Steven R. Singer
Editor Michael Buller
Design John DiGianni
Associate Editor Robert Levy
Articles Editor Saul Wisnia
Managing Editor Eric Schuller
Contributors Cindy Hutter, Debra Bradley Ruder, Richard Saltus
Production Assistance Patrice Bedard, Jacqueline Czel, Kimberly Regensburg, Lee Whale
Photography Sam Ogden, Getty Images

Paths of Progress is published twice a year by Dana-Farber Cancer Institute's Department of Communications. If you have any comments or would like to be removed from the mailing list, contact:

Michael Buller
Editor, Paths of Progress
Dana-Farber Cancer Institute, Department of Communications
44 Binney Street
Boston, MA 02115-6084

(617) 632-4090
michael_buller@dfci.harvard.edu

Copyright © 2009 Dana-Farber Cancer Institute. All rights reserved.

Paths of Progress Archive

E-mail this page